SPL Set ID: e5e89bff-6ced-4165-acc5-fb13136b3a3d
1 drug(s) with this SPL Set ID
RHAPSIDO (remibrutinib) is a kinase inhibitor. Its empirical formula (remibrutinib) is C 27 H 27 F 2 N 5 O 3 . The chemical name for remibrutinib is N-(3-{6-Amino-5-[2-(N-methylprop-2-enamido)ethoxy]pyrimidin-4-yl}-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide. Its molecular weight is approximately 507.54 g/mol. The chemical structure of remibrutinib is: Remibrutinib is white to pale yellow powder, and it is practically insoluble in water. RHAPSIDO is supplied as film-coated tablets for oral administration, with each film-coated tablet containing 25 mg of remibrutinib. The tablet core inactive ingredients are copovidone, croscarmellose sodium, mannitol, microcrystalline cellulose, sodium lauryl sulfate, and sodium stearyl fumarate. The tablet coating inactive ingredients are polyethylene glycol 4000, polyvinyl alcohol, red iron oxide (E172), talc, titanium dioxide (E171), and yellow iron oxide (E172). chemical structure of remibrutinib